These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10923602)

  • 1. Adrenocortical function in patients with severe atopic dermatitis.
    Matsuda K; Katsunuma T; Iikura Y; Kato H; Saito H; Akasawa A
    Ann Allergy Asthma Immunol; 2000 Jul; 85(1):35-9. PubMed ID: 10923602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused.
    Haeck IM; Timmer-de Mik L; Lentjes EG; Buskens E; Hijnen DJ; Guikers C; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    Br J Dermatol; 2007 May; 156(5):979-85. PubMed ID: 17298484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
    Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
    Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
    Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
    Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenocortical suppression by topically applied corticosteroids in healthy dogs.
    Zenoble RD; Kemppainen RJ
    J Am Vet Med Assoc; 1987 Sep; 191(6):685-8. PubMed ID: 2824410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
    Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
    Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low bone mineral density in adult patients with moderate to severe atopic dermatitis.
    Haeck IM; Hamdy NA; Timmer-de Mik L; Lentjes EG; Verhaar HJ; Knol MJ; de Bruin-Weller MS; Bruijnzeel-Koomen CA
    Br J Dermatol; 2009 Dec; 161(6):1248-54. PubMed ID: 19673879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of pimecrolimus cream 1% to a topical corticosteroid treatment regimen in paediatric patients with severe atopic dermatitis: a randomized, double-blind trial.
    Meurer M; Eichenfield LF; Ho V; Potter PC; Werfel T; Hultsch T
    J Dermatolog Treat; 2010 May; 21(3):157-66. PubMed ID: 20394491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of glucocorticoid receptor beta in lymphocytes of patients with severe atopic dermatitis unresponsive to topical corticosteroid.
    Hägg PM; Hurskainen T; Palatsi R; Ilves M; Oikarinen A
    Br J Dermatol; 2010 Feb; 162(2):318-24. PubMed ID: 19903176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study.
    Szczepanowska J; Reich A; Szepietowski JC
    Pediatr Allergy Immunol; 2008 Nov; 19(7):614-8. PubMed ID: 18208463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study.
    van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    Br J Dermatol; 2009 Mar; 160(3):687-91. PubMed ID: 19120337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
    Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
    J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atopic dermatitis in children in the United States, 1997-2004: visit trends, patient and provider characteristics, and prescribing patterns.
    Horii KA; Simon SD; Liu DY; Sharma V
    Pediatrics; 2007 Sep; 120(3):e527-34. PubMed ID: 17766497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis.
    Luger TA; Lahfa M; Fölster-Holst R; Gulliver WP; Allen R; Molloy S; Barbier N; Paul C; Bos JD
    J Dermatolog Treat; 2004 Jun; 15(3):169-78. PubMed ID: 15204150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cushing's syndrome induced by misuse of moderate- to high-potency topical corticosteroids.
    Coureau B; Bussières JF; Tremblay S
    Ann Pharmacother; 2008 Dec; 42(12):1903-7. PubMed ID: 19017822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous absorption of potent topical corticosteroids in patients with severe atopic dermatitis.
    van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA
    J Am Acad Dermatol; 2010 Nov; 63(5):911-3. PubMed ID: 20950744
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis.
    Ellison JA; Patel L; Ray DW; David TJ; Clayton PE
    Pediatrics; 2000 Apr; 105(4 Pt 1):794-9. PubMed ID: 10742322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.